76 related articles for article (PubMed ID: 10463595)
1. The protein kinase C inhibitor CGP41251 suppresses cytokine release and extracellular signal-regulated kinase 2 expression in cancer patients.
Thavasu P; Propper D; McDonald A; Dobbs N; Ganesan T; Talbot D; Braybrook J; Caponigro F; Hutchison C; Twelves C; Man A; Fabbro D; Harris A; Balkwill F
Cancer Res; 1999 Aug; 59(16):3980-4. PubMed ID: 10463595
[TBL] [Abstract][Full Text] [Related]
2. Effects of the kinase inhibitor CGP41251 (PKC 412) on lymphocyte activation and TNF-alpha production.
Si MS; Reitz BA; Borie DC
Int Immunopharmacol; 2005 Jul; 5(7-8):1141-9. PubMed ID: 15914319
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of CGP41251, a new selective protein kinase C inhibitor, on human non-small cell lung cancer cells.
Ikegami Y; Yano S; Nakao K
Jpn J Pharmacol; 1996 Jan; 70(1):65-72. PubMed ID: 8822090
[TBL] [Abstract][Full Text] [Related]
4. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
Luo W; Sharif TR; Houghton PJ; Sharif M
Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245
[TBL] [Abstract][Full Text] [Related]
5. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway.
Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM
Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122
[TBL] [Abstract][Full Text] [Related]
6. Analogs of staurosporine: potential anticancer drugs?
Gescher A
Gen Pharmacol; 1998 Nov; 31(5):721-8. PubMed ID: 9809468
[TBL] [Abstract][Full Text] [Related]
7. PKC412--a protein kinase inhibitor with a broad therapeutic potential.
Fabbro D; Ruetz S; Bodis S; Pruschy M; Csermak K; Man A; Campochiaro P; Wood J; O'Reilly T; Meyer T
Anticancer Drug Des; 2000 Feb; 15(1):17-28. PubMed ID: 10888033
[TBL] [Abstract][Full Text] [Related]
8. LPS-Induced NF-kappaB activation and TNF-alpha release in human monocytes are protein tyrosine kinase dependent and protein kinase C independent.
Shames BD; Selzman CH; Pulido EJ; Meng X; Meldrum DR; McIntyre RC; Harken AH; Banerjee A
J Surg Res; 1999 May; 83(1):69-74. PubMed ID: 10210645
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C as a drug target: implications for drug or diet prevention and treatment of cancer.
Carter CA
Curr Drug Targets; 2000 Sep; 1(2):163-83. PubMed ID: 11465069
[TBL] [Abstract][Full Text] [Related]
10. A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C.
Virchis A; Ganeshaguru K; Hart S; Jones D; Fletcher L; Wright F; Wickremasinghe R; Man A; Csermak K; Meyer T; Fabbro D; Champain K; Yap A; Prentice HG; Mehta A
Hematol J; 2002; 3(3):131-6. PubMed ID: 12111648
[TBL] [Abstract][Full Text] [Related]
11. Differential activation of T cell cytokine production by the extracellular signal-regulated kinase (ERK) signaling pathway.
Egerton M; Fitzpatrick DR; Catling AD; Kelso A
Eur J Immunol; 1996 Oct; 26(10):2279-85. PubMed ID: 8898934
[TBL] [Abstract][Full Text] [Related]
12. Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-alpha and GM-CSF.
McLeish KR; Knall C; Ward RA; Gerwins P; Coxon PY; Klein JB; Johnson GL
J Leukoc Biol; 1998 Oct; 64(4):537-45. PubMed ID: 9766635
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Tamir A; Granot Y; Isakov N
J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
[TBL] [Abstract][Full Text] [Related]
14. Involvement of protein kinases in the induction of NO synthase II in human DLD-1 cells.
Kleinert H; Euchenhofer C; Fritz G; Ihrig-Biedert I; Förstermann U
Br J Pharmacol; 1998 Apr; 123(8):1716-22. PubMed ID: 9605580
[TBL] [Abstract][Full Text] [Related]
15. EGF-mediated phosphorylation of extracellular signal-regulated kinases in osteoblastic cells.
Zhang W; Dziak RM; Aletta JM
J Cell Physiol; 1995 Mar; 162(3):348-58. PubMed ID: 7860643
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a drug activity biomarker that shows target inhibition in cancer patients receiving enzastaurin, a novel protein kinase C-beta inhibitor.
Green LJ; Marder P; Ray C; Cook CA; Jaken S; Musib LC; Herbst RS; Carducci M; Britten CD; Basche M; Eckhardt SG; Thornton D
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3408-15. PubMed ID: 16740765
[TBL] [Abstract][Full Text] [Related]
17. [PKC 412].
Lansiaux A; Fabbro D; Meyer T; Hamy F; Bailly C
Bull Cancer; 1999; 86(7-8):614-7. PubMed ID: 10477377
[No Abstract] [Full Text] [Related]
18. Participation of protein kinases in staurosporine-induced interleukin-6 production by rat peritoneal macrophages.
Yamaki K; Ohuchi K
Br J Pharmacol; 1999 Jul; 127(6):1309-16. PubMed ID: 10455280
[TBL] [Abstract][Full Text] [Related]
19. Negative regulatory role of PI3-kinase in TNF-induced tumor necrosis.
Matschurat S; Blum S; Mitnacht-Kraus R; Dijkman HB; Kanal L; De Waal RM; Clauss M
Int J Cancer; 2003 Oct; 107(1):30-7. PubMed ID: 12925953
[TBL] [Abstract][Full Text] [Related]
20. Extracellular signal-regulated kinase, stress-activated protein kinase/c-Jun N-terminal kinase, and p38mapk are involved in IL-10-mediated selective repression of TNF-alpha-induced activation and maturation of human peripheral blood monocyte-derived dendritic cells.
Sato K; Nagayama H; Tadokoro K; Juji T; Takahashi TA
J Immunol; 1999 Apr; 162(7):3865-72. PubMed ID: 10201904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
